Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
MCRB
4 quarters
Position history for JPMorgan Chase & Co.'s holdings in Seres Therapeutics, Inc.
Yes. JPMorgan Chase holds 3,636 shares of MCRB (Seres Therapeutics), worth $28,325, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$28,325
Current Shares
3,636
Total Value Change
+$27,603
Total Shares Change
+3,571
Quarter-by-Quarter History
Other major holders of MCRB: Vanguard Group Inc., FMR LLC, Susquehanna International Group, LLP